Spruce Street Capital Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Spruce Street Capital Lp disclosed 28 stock positions valued at approximately $509.68M as of quarter-end June 30, 2026. The largest holdings include KINIKSA PHARMACEUTICALS INTL, RELAY THERAPEUTICS INC, and LB PHARMACEUTICALS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 28
- Portfolio Value
- $509.68M
Holdings by Sector
Spruce Street Capital Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| KINIKSA PHARMACEUTICALS INTL | KNSA | Other | 11.52% | 918,070 | +157,007 | +20.63% | $58,710,577 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 10.95% | 2,984,125 | - | - | $55,832,979 |
| LB PHARMACEUTICALS INC | LBRX | Other | 8.76% | 1,376,159 | - | - | $44,663,240 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 8.68% | 6,391,328 | +129,214 | +2.06% | $44,227,990 |
| ALTO NEUROSCIENCE INC | ANRO | Healthcare | 7.01% | 1,353,047 | +27,837 | +2.10% | $35,706,910 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 6.79% | 354,816 | -18,458 | -4.94% | $34,587,464 |
| ALKERMES PLC | ALKS | Healthcare | 5.59% | 543,876 | +225,884 | +71.03% | $28,496,383 |
| SAVARA INC | SVRA | Healthcare | 4.17% | 3,452,576 | +69,401 | +2.05% | $21,267,868 |
| VAXCYTE INC | PCVX | Healthcare | 3.49% | 306,047 | +60,338 | +24.56% | $17,790,512 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 3.28% | 329,006 | - | - | $16,697,055 |
| ENANTA PHARMACEUTICALS INC | ENTA | Healthcare | 3.11% | 1,088,731 | +156,133 | +16.74% | $15,873,698 |
| PERSPECTIVE THERAPEUTICS INC | CATX | Healthcare | 2.47% | 3,693,931 | +1,066,824 | +40.61% | $12,596,305 |
| INFLARX NV | IFRX | Other | 2.35% | 5,352,198 | +5,352,198 | +100.00% | $11,988,924 |
| SURROZEN INC | SRZN | Healthcare | 2.20% | 432,040 | - | - | $11,211,438 |
| ALUMIS INC | ALMS | Healthcare | 2.17% | 392,574 | - | - | $11,047,032 |
| CENTURY THERAPEUTICS INC | IPSC | Healthcare | 1.95% | 4,059,054 | - | - | $9,944,682 |
| MINERVA NEUROSCIENCES INC | NERV | Healthcare | 1.80% | 1,655,500 | - | - | $9,188,025 |
| SAB BIOTHERAPEUTICS INC | SABS | Healthcare | 1.68% | 2,198,502 | - | - | $8,574,158 |
| AN2 THERAPEUTICS INC | ANTX | Healthcare | 1.58% | 1,661,073 | - | - | $8,039,593 |
| ERASCA INC | ERAS | Healthcare | 1.52% | 422,543 | - | - | $7,740,988 |
| INHIBIKASE THERAPEUTICS INC | IKT | Healthcare | 1.43% | 3,581,603 | - | - | $7,270,654 |
| RESEARCH ALLIANCE CORP III | RACC | Other | 1.05% | 500,000 | +500,000 | +100.00% | $5,350,000 |
| ZAI LAB LTD | ZLAB | Healthcare | 1.04% | 279,110 | +279,110 | +100.00% | $5,303,090 |
| ACHIEVE LIFE SCIENCE INC | ACHV | Healthcare | 0.94% | 736,637 | +736,637 | +100.00% | $4,810,240 |
| LEXEO THERAPEUTICS INC | LXEO | Healthcare | 0.85% | 928,593 | - | - | $4,322,600 |
| ALECTOR INC | ALEC | Healthcare | 0.83% | 2,101,068 | - | - | $4,223,147 |
| LEONABIO INC | LONA | Other | 0.71% | 393,701 | - | - | $3,618,112 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 0.68% | 231,585 | - | - | $3,459,880 |
Showing 28 of 28 holdings in the latest reporting period.